Your browser is no longer supported. Please, upgrade your browser.
Settings
ASMB Assembly Biosciences, Inc. daily Stock Chart
ASMB [NASD]
Assembly Biosciences, Inc.
Index- P/E- EPS (ttm)-4.00 Insider Own0.90% Shs Outstand24.39M Perf Week-15.46%
Market Cap404.14M Forward P/E- EPS next Y-5.18 Insider Trans0.00% Shs Float22.56M Perf Month-11.53%
Income-90.80M PEG- EPS next Q-1.07 Inst Own85.40% Short Float8.17% Perf Quarter-22.02%
Sales14.80M P/S27.31 EPS this Y-37.40% Inst Trans0.14% Short Ratio6.11 Perf Half Y-35.37%
Book/sh8.26 P/B2.01 EPS next Y-17.20% ROA-42.70% Target Price65.00 Perf Year-64.47%
Cash/sh8.94 P/C1.85 EPS next 5Y17.00% ROE-57.50% 52W Range13.13 - 48.91 Perf YTD-26.75%
Dividend- P/FCF- EPS past 5Y4.50% ROI-44.50% 52W High-66.12% Beta1.73
Dividend %- Quick Ratio12.00 Sales past 5Y- Gross Margin- 52W Low26.20% ATR1.52
Employees95 Current Ratio12.00 Sales Q/Q12.10% Oper. Margin- RSI (14)39.30 Volatility11.41% 7.70%
OptionableYes Debt/Eq0.00 EPS Q/Q-68.10% Profit Margin- Rel Volume1.60 Prev Close16.09
ShortableYes LT Debt/Eq0.00 EarningsMar 14 AMC Payout- Avg Volume301.60K Price16.57
Recom1.40 SMA20-11.99% SMA50-17.75% SMA200-39.85% Volume482,516 Change2.98%
Nov-19-18Initiated Leerink Partners Outperform $45
Oct-08-18Upgrade B. Riley FBR Neutral → Buy $42
Aug-08-18Initiated Robert W. Baird Outperform $74
Apr-13-18Downgrade Chardan Capital Markets Buy → Neutral $35 → $50
Jan-05-18Initiated B. Riley FBR, Inc. Neutral $35
Nov-08-17Initiated Jefferies Buy $50
May-30-17Initiated Chardan Capital Markets Buy $35
Apr-15-19 01:37PM  Here's Why Assembly Biosciences Is Slipping Today Motley Fool -21.34%
Apr-13-19 12:00PM  Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019 GlobeNewswire
Apr-11-19 07:05AM  Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019 GlobeNewswire
Apr-02-19 07:07AM  4 Biotech Stocks With Major Catalysts in April Motley Fool
Mar-27-19 07:05AM  Assembly Biosciences Announces Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019 GlobeNewswire +6.00%
Mar-13-19 07:05AM  Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit GlobeNewswire
Mar-06-19 01:35PM  If You Had Bought Assembly Biosciences Stock Three Years Ago, You Could Pocket A 261% Gain Today Simply Wall St. -6.43%
Feb-28-19 05:00PM  Assembly Biosciences Reports Fourth Quarter and Year End 2018 Financial Results GlobeNewswire
Feb-19-19 05:47PM  Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects Zacks
Feb-13-19 08:25AM  Market Trends Toward New Normal in Brighthouse Financial, BioMarin Pharmaceutical, EZCORP, Assembly Biosciences, A-Mark Precious Metals, and American Public Education Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-31-19 09:30AM  Mylan (MYL) Jumps: Stock Rises 7.1% Zacks
Jan-15-19 12:24PM  Assembly Biosciences, Inc. (NASDAQ:ASMB) Insiders Increased Their Holdings Simply Wall St. +5.79%
Jan-07-19 07:00AM  Assembly Biosciences Announces Completion of Enrollment in Two Phase 2a Studies with ABI-H0731 for Chronic Hepatitis B Virus GlobeNewswire
Dec-16-18 09:04AM  Here is What Hedge Funds Think About Assembly Biosciences Inc (ASMB) Insider Monkey
Dec-03-18 08:52AM  Amphastar Pharmaceuticals (AMPH) Catches Eye: Stock Jumps 6.7% Zacks
Nov-30-18 08:17AM  Should You Worry About Assembly Biosciences Incs (NASDAQ:ASMB) CEO Pay? Simply Wall St.
Nov-12-18 07:05AM  Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD GlobeNewswire
Nov-08-18 11:10AM  Assembly Biosciences (ASMB) Reports Q3 Loss, Tops Revenue Estimates Zacks +11.26%
10:04AM  Assembly Biosciences: 3Q Earnings Snapshot Associated Press
07:00AM  Assembly Biosciences Announces Third Quarter 2018 Financial Results and Provides HBV Program Update GlobeNewswire
Oct-31-18 10:32AM  Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for Zacks
07:00AM  Assembly Biosciences Announces November Conference Participation GlobeNewswire
Oct-16-18 07:36AM  Report: Developing Opportunities within The Ensign Group, Forterra, Inc., Audentes Therapeutics, Assembly Biosciences, Capital Senior Living, and Myomo Future Expectations, Projections Moving into 2018 GlobeNewswire +6.88%
Oct-08-18 03:16PM  Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade Benzinga
Oct-02-18 07:05AM  Assembly Biosciences Announces Oral Presentation at 2018 AASLD GlobeNewswire
Oct-01-18 08:43AM  Shareholders Should Check The Ownership Structure Of Assembly Biosciences Inc (NASDAQ:ASMB) Simply Wall St.
Aug-28-18 07:05AM  Assembly Biosciences to Present at Upcoming Investor Conferences GlobeNewswire
Aug-16-18 07:35AM  Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-08-18 08:25PM  Assembly Biosciences (ASMB) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:19PM  Assembly Biosciences: 2Q Earnings Snapshot Associated Press
04:05PM  Assembly Biosciences Announces Second Quarter 2018 Financial Results GlobeNewswire
Jul-25-18 07:05AM  Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H0731 for the Treatment of Hepatitis B Virus Infection GlobeNewswire
Jul-16-18 04:05PM  Assembly Biosciences Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire
Jul-11-18 07:29PM  Assembly Biosciences Announces Pricing of $144 Million Offering of Common Stock GlobeNewswire -7.72%
Jul-10-18 04:01PM  Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock GlobeNewswire
Jul-09-18 07:05AM  Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection GlobeNewswire
Jun-13-18 07:05AM  Assembly Biosciences to Host Research and Development Day on Wednesday, June 20, 2018 GlobeNewswire
Jun-08-18 07:05AM  Assembly Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire +12.92%
Jun-04-18 07:00AM  Assembly Biosciences to Participate in Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-29-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Assembly Biosciences, MGP Ingredients, Globant S.A, 8point3 Energy Partners LP, Flexion Therapeutics, and Enanta Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
May-07-18 05:57PM  Assembly Biosciences: 1Q Earnings Snapshot Associated Press
04:05PM  Assembly Biosciences Announces First Quarter 2018 Financial Results GlobeNewswire
Apr-13-18 10:31AM  Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson Benzinga -7.70%
Apr-12-18 07:59AM  Was Assembly Biosciences Incs (NASDAQ:ASMB) Earnings Growth Better Than The Industrys? Simply Wall St.
03:10AM  Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference GlobeNewswire
Apr-10-18 05:40PM  Assembly Biosciences to Host Conference Call on April 12 to Review ABI-H0731 Interim Phase 1b Data in HBV Patients Featured in Late-Breaker Poster at EASL GlobeNewswire
Apr-04-18 08:00AM  Report: Developing Opportunities within Assembly Biosciences, Guaranty, Noble Midstream Partners LP, Lithia Motors, Vectrus, and Kforce Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-02-18 04:54PM  Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome GlobeNewswire
07:30AM  Blog Exposure - Assembly Biosciences to Present ABI-H0731 Phase-1b Interim Data at The International Liver Congress(TM) ACCESSWIRE
Mar-28-18 05:30AM  Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress (EASL) GlobeNewswire -7.44%
Mar-12-18 07:05AM  Assembly Biosciences Announces Additions to Management Team and Board of Directors GlobeNewswire +9.80%
Mar-05-18 07:00AM  Assembly Biosciences to Present at Cowens 38th Annual Healthcare Conference GlobeNewswire
Feb-06-18 08:00AM  Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward Discovering Underlying Factors of Influence GlobeNewswire
Feb-05-18 07:05AM  Assembly Biosciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
Feb-02-18 04:30PM  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-04-18 07:05AM  Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-17 04:05PM  Assembly Biosciences Appoints Sue Mahony, PhD to Board of Directors GlobeNewswire +8.18%
Dec-08-17 05:53PM  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Nov-28-17 07:02AM  Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences Zacks +6.91%
Nov-08-17 07:00AM  Assembly Biosciences to Present at the Jefferies London Healthcare Conference GlobeNewswire +8.42%
Nov-02-17 12:40AM  Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock GlobeNewswire
Nov-01-17 04:01PM  Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock GlobeNewswire
Oct-26-17 11:01AM  Assembly Biosciences, Inc. Value Analysis (NASDAQ:ASMB) : October 26, 2017 Capital Cube
Oct-25-17 08:14AM  Assembly Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : ASMB-US : October 25, 2017 Capital Cube
Oct-05-17 07:00AM  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Oct-02-17 07:00AM  Assembly Biosciences Announces 2017 AASLD Presentations GlobeNewswire
Sep-25-17 07:00AM  Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development GlobeNewswire
Sep-18-17 07:51AM  New Strong Sell Stocks for September 18th Zacks
Aug-31-17 10:30AM  New Strong Sell Stocks for August 31st Zacks
07:00AM  Assembly Biosciences Announces September Conference Participation GlobeNewswire
Aug-16-17 10:00AM  New Strong Sell Stocks for August 16th Zacks
Aug-15-17 05:34PM  Assembly Biosciences, Inc. Value Analysis (NASDAQ:ASMB) : August 15, 2017 Capital Cube
Aug-02-17 08:32AM  Assembly Biosciences, Inc. breached its 50 day moving average in a Bullish Manner : ASMB-US : August 2, 2017 Capital Cube
Jul-28-17 04:30PM  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jun-15-17 01:06PM  ETFs with exposure to Assembly Biosciences, Inc. : June 15, 2017 Capital Cube
Jun-13-17 08:51AM  Assembly Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : ASMB-US : June 13, 2017 Capital Cube
May-26-17 07:00AM  Assembly Biosciences Announces June Conference Presentations GlobeNewswire
May-11-17 06:11PM  Assembly Biosciences, Inc. Value Analysis (NASDAQ:ASMB) : May 11, 2017 Capital Cube
May-09-17 08:53AM  Assembly Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : ASMB-US : May 9, 2017 Capital Cube
Mar-08-17 01:04PM  ASSEMBLY BIOSCIENCES, INC. Financials
Mar-02-17 06:04AM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
Feb-21-17 07:05AM  Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan GlobeNewswire
Feb-16-17 07:05AM  Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations GlobeNewswire
Jan-18-17 08:35AM  Assembly Biosciences (ASMB) Looks Good: Stock Up 13.9% Zacks
Jan-10-17 07:01AM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure,
Jan-09-17 11:13AM  Allergan Continues Down 'Stepping Stone' Path With Two Deals TheStreet.com
11:13AM  [video]Allergan Continues Down 'Stepping Stone' Path With Two Deals
08:23AM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs PR Newswire
Dec-19-16 11:15PM  Is Assembly Biosciences Inc (ASMB) A Good Stock To Buy According To Hedge Funds? Insider Monkey
11:15PM  Is Assembly Biosciences Inc (ASMB) A Good Stock To Buy According To Hedge Funds? at Insider Monkey
Dec-09-16 04:02PM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
Dec-02-16 04:06PM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-29-16 12:00PM  Assembly Biosciences, Inc. :ASMB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 Capital Cube
12:00PM  Assembly Biosciences, Inc. :ASMB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-11-16 08:00AM  Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting GlobeNewswire
Nov-09-16 07:05AM  Assembly Biosciences Initiates Phase 1 Clinical Program of ABI-H0731 for Treatment of Chronic Hepatitis B Virus Infection GlobeNewswire
07:01AM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:13AM  ASSEMBLY BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Oct-17-16 08:45AM  Assembly Biosciences (ASMB) Worth a Look: Stock Up 7.3%
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to treat disorders associated with the microbiome. It is involved in the development of core inhibitors that inhibit the functional activities of HBV core protein at various points in the viral lifecycle. The company's microbiome program consists of an integrated platform that includes the disease-targeted strain isolation, identification, characterization, and selection process for strain purification and growth under current good manufacturing practice conditions; and a licensed patented delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Its product candidates include ABI-H0731 that is in two Phase 2a clinical trials for the treatment of HBV; ABI-H2158, which is in Phase 1a/1b dose-ranging clinical study in the HBV-cure program; and ABI-H3733 that is in investigational new drug-enabling studies for the treatment of HBV. In addition, the company engages in the development of product candidates for various disease indications, such as Crohn's disease, irritable bowel syndrome, non-alcoholic steatohepatitis, and immuno-oncology by using its microbiome platform. It has a collaboration agreement with Allergan Pharmaceuticals International Limited for the development and commercialization of various microbiome gastrointestinal programs. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lopatin Uri AChief Med. Off., VP Res. Dev.Sep 06Sale40.0133613,442613,611Sep 07 04:44 PM
Lopatin Uri AChief Med. Off., VP Res. Dev.Sep 05Sale40.0915,204609,547613,947Sep 07 04:44 PM
Small Derek ACEO and PresidentJul 19Buy41.482,40099,551669,291Jul 20 04:01 PM
RINGO WILLIAM RDirectorJul 02Option Exercise7.201,0007,20020,465Jul 03 04:00 PM
RINGO WILLIAM RDirectorJul 02Sale38.501,00038,50319,465Jul 03 04:00 PM
RINGO WILLIAM RDirectorJun 01Option Exercise7.201,0007,20020,465Jun 01 05:54 PM
RINGO WILLIAM RDirectorJun 01Sale42.471,00042,47019,465Jun 01 05:54 PM
RINGO WILLIAM RDirectorMay 01Option Exercise7.201,0007,20020,465May 02 04:05 PM
RINGO WILLIAM RDirectorMay 01Sale43.061,00043,06019,465May 02 04:05 PM